Anti-ICAM1 antibody [EP1442Y]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(70 Publications)
Rabbit Recombinant Monoclonal ICAM1 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 70 publications.
View Alternative Names
CD54, Intercellular adhesion molecule 1, ICAM-1, Major group rhinovirus receptor, ICAM1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ICAM1 antibody [EP1442Y] (AB53013)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human tonsil tissue sections labeling ICAM1 with purified ab53013 at 1/500 dilution (0.22 µg/mL). Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0). The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ICAM1 antibody [EP1442Y] (AB53013)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human kidney tissue sections labeling ICAM1 with purified ab53013 at 1/500 dilution (0.22 µg/mL). Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0). The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- WB
Lab
Western blot - Anti-ICAM1 antibody [EP1442Y] (AB53013)
Lanes 1-4 : Merged signal (red and green). Green - ab53013 observed at 90 kDa. Red - loading control ab8245 observed at 36 kDa.
ab53013 Anti-ICAM1 antibody [EP1442Y] was shown to specifically react with ICAM1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab261742 (knockout cell lysate ab256947) was used. Wild-type and ICAM1 knockout samples were subjected to SDS-PAGE. ab53013 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ICAM1 antibody [EP1442Y] (ab53013) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ICAM1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human ICAM1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-icam1-knockout-hela-cell-line-ab261742'>ab261742</a>)
Lane 3:
Raji cell lysate at 20 µg
Lane 4:
Ramos cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 57 kDa
Observed band size: 90 kDa
false
- WB
Lab
Western blot - Anti-ICAM1 antibody [EP1442Y] (AB53013)
False colour image of Western blot : Anti-ICAM1 antibody [EP1442Y] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab53013 was shown to bind specifically to ICAM1. A band was observed at 90 kDa in wild-type HeLa cell lysates with no signal observed at this size in Icam1 CRISPR-Cas9 edited cell line ab261742 (CRISPR-Cas9 edited cell lysate ab256947). The band observed in the CRISPR-Cas9 edited lysate lane below 90 kDa (not observed by this antibody) is likely to represent a truncated form of ICAM1. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and Icam1 CRISPR-Cas9 edited HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-ICAM1 antibody [EP1442Y] (ab53013) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ICAM1 CRISPR-Cas9 edited HeLa cell lysate at 20 µg
Lane 3:
A549 cell lysate at 20 µg
Lane 4:
Ramos cell lysate at 20 µg
Predicted band size: 57 kDa
Observed band size: 90 kDa
false
- WB
Lab
Western blot - Anti-ICAM1 antibody [EP1442Y] (AB53013)
False colour image of Western blot : Anti-ICAM1 antibody [EP1442Y] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab53013 was shown to bind specifically to ICAM1. A band was observed at 90 kDa in wild-type HeLa cell lysates with no signal observed at this size in Icam1 knockout cell line ab261742 (knockout cell lysate ab256947). The band observed in the knockout lysate lane below 90 kDa (not observed by this antibody) is likely to represent a truncated form of ICAM1. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and Icam1 knockout HeLa cell lysates were analysed.First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-ICAM1 antibody [EP1442Y] (ab53013) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ICAM1 knockout HeLa cell lysate at 20 µg
Lane 3:
A549 cell lysate at 20 µg
Lane 4:
Ramos cell lysate at 20 µg
Predicted band size: 57 kDa
Observed band size: 90 kDa
false
- WB
Unknown
Western blot - Anti-ICAM1 antibody [EP1442Y] (AB53013)
The molecular mass observed is consistent with what has been described in the literatures (PMID : 29777158, 30082828, 31244919).
All lanes:
Western blot - Anti-ICAM1 antibody [EP1442Y] (ab53013) at 1/1000 dilution
Lane 1:
Untreated HUVEC (Human umbilical vein endothelial cell) whole cell lysate at 20 µg
Lane 2:
HUVEC (Human umbilical vein endothelial cell) treated with 50ng/ml TNF-α for 24 hours whole cell lysate at 20 µg
Lane 3:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
false
Related conjugates and formulations (7)
-
Anti-ICAM1 antibody [EP1442Y] - BSA and Azide free
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-ICAM1 antibody [EP1442Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-ICAM1 antibody [EP1442Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-ICAM1 antibody [EP1442Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ICAM1 antibody [EP1442Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-ICAM1 antibody [EP1442Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-ICAM1 antibody [EP1442Y]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (70)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:701 PubMed41053006
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 30:132 PubMed39187765
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Molecular basis of disease 1870:167479 PubMed39181516
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:110350 PubMed39108722
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:108898 PubMed38322992
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:82 PubMed38291428
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 13:e1377 PubMed37598403
2023
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e22942 PubMed37178006
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 13:973871 PubMed37124539
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:1059124 PubMed36794234
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com